Established in 1966 as the Nuclear Medicine Society, its membership includes the clinicians dealing with the medical speciality, clinical scientists, radiopharmacists, other scientists, nuclear medicine technologists and nurses.
BNMS Hybrid Imaging Meeting - Abstract Submission now open.
The BNMS Council have decided that this year there will be no scientific paper session in the autumn meetings. There will however be an opportunity to present your work as posters during the meeting.
|Submit an abstract HERE
This year there is no template to upload abstracts.
Deadline for abstract submission Noon, 8th July 2013
Further to our previous communication regarding Indium Oxine and Chloride withdrawal from the european market, please see the following message from the UK radiopharmacy group about alternative methods for labelling blood cells with In-111 Indium Chloride:
Following the imminent withdrawal from the UK market of Indium Oxine (INS15P) and Indium Chloride (INS1P) by GE Healthcare, alternative methods for labelling blood cells with In-111 Indium chloride have been sought. A published method is available in Sampson’s textbook of Radiopharmacy 4th edition p438 439. Pharmaceutical Press. London. 2011 ISBN 978 0 85369 789 3. Note this method will require validation by the user before use in patients and the ASRAC certificate holder remains responsible for the clinical procedure
A suitable licensed alternative to INS1P is available from Mallinckrodt (DRN4901 – 111MBq).
Paul Maltby, Bev Ellis and Jilly Croasdale, May 2013
The British Nuclear Medicine Society would like to thank the following sponsors for the their support of the 2013 Annual Spring Meeting in Brighton.